HUM - Humana Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $343.06 DETAILS

Stock News

Humana Inc. (NYSE: HUM) Investor Reminder: Schubert Jonckheer Investigating Possible False Statements Following 22% Stock Drop

SAN FRANCISCO, July 27, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP reminds Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the company's exposure to increased healthcare utilization costs. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/humana.

Jul 27, 2026 05:00 AM • prnewswire.com

Caxton Associates LLP Makes New Investment in Humana Inc. $HUM

Caxton Associates LLP bought a new stake in Humana Inc. (NYSE: HUM) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,646 shares of the insurance provider's stock, valued at approximately $979,000. Several other institutional investors also recently made changes to their

Jul 27, 2026 12:54 AM • defenseworld.net

Delta Global Management LP Purchases Shares of 5,521 Humana Inc. $HUM

Delta Global Management LP purchased a new position in shares of Humana Inc. (NYSE: HUM) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,521 shares of the insurance provider's stock, valued at approximately $957,000. Other hedge

Jul 27, 2026 12:11 AM • defenseworld.net

Can Humana Beat Q2 Earnings Estimates on Growing Premiums?

HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.

Jul 24, 2026 09:41 AM • zacks.com

IMAX price target boosted by Wedbush on growth outlook

IMAX Corp (NYSE:IMAX) received a price target increase from Wedbush to $54 from $46, with the firm reiterating its Outperform rating as it expects continued...

Jul 24, 2026 03:31 AM • proactiveinvestors.com

Wise tumbles as US regulator rejects banking licence application

Wise Group PLC (LSE:WISE, NASDAQ:WSE) shares fell 9% to 824p after US regulators rejected its application for a national trust bank charter. The US Office...

Jul 24, 2026 01:14 AM • proactiveinvestors.com

Freeport-McMoRan shares slip despite second quarter earnings beat as copper outlook softens

Freeport-McMoRan Inc (NYSE:FCX, XETRA:FPMB) reported stronger-than-expected second quarter 2026 results on Thursday, with earnings and revenue topping Wall...

Jul 23, 2026 05:07 AM • proactiveinvestors.com

Custom Health wins Buy rating from Stifel, then seals a pharmacy deal to match

Custom Health Holdings Inc (TSX:CHLT) just landed Buy-rated coverage from Stifel, with analysts setting a C$12 price target and pointing to upside as high...

Jul 23, 2026 04:28 AM • proactiveinvestors.com

Kaskela Law Firm Announces Investigation of Humana Inc. (HUM) and Encourages Long-Term HUM Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/humana/ Recently a federal securities fraud complaint was filed against Humana on behalf of certain investors who purchased shares of the company's stock between July 27, 2022 and October 1, 2024 (the “Wrongdoing Period”). According to the compla.

Jul 23, 2026 03:00 AM • businesswire.com

Nomura Core Equity Fund Q2 2026 Portfolio Review

Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions. On balance, the Fund's artificial intelligence positioning was a net positive contributor to relative performance during the quarter. We added the Humana position on the view that earnings are at a cyclical trough, with MA margins currently depressed, in some cases negative, as elevated medical cost trends have outpaced premium growth across the industry.

Jul 22, 2026 08:35 AM • seekingalpha.com

Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?

Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Jul 22, 2026 07:01 AM • zacks.com

Humana Inc. $HUM Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its holdings in shares of Humana Inc. (NYSE: HUM) by 24.4% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 171,183 shares of the insurance provider's stock after selling 55,174 shares during the period. California Public Employees Retirement System

Jul 21, 2026 11:45 PM • defenseworld.net

Humana (HUM) is a Great Momentum Stock: Should You Buy?

Does Humana (HUM) have what it takes to be a top stock pick for momentum investors? Let's find out.

Jul 21, 2026 09:01 AM • zacks.com

Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?

Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.

Jul 17, 2026 06:46 AM • zacks.com

Can Humana (HUM) Run Higher on Rising Earnings Estimates?

Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Jul 16, 2026 09:21 AM • zacks.com

Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027

A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you capture the savings depends on a coverage question most people do not realize they are answering.

Jul 16, 2026 05:16 AM • benzinga.com

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.

Jul 13, 2026 09:40 AM • zacks.com

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026

Jul 03, 2026 09:00 AM • gurufocus.com

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Jul 03, 2026 08:49 AM • prnewswire.com

The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.

Jun 30, 2026 04:00 AM • businesswire.com